Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phosphoramidite. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced nanofiltration technology purifies oligonucleotide synthons enhancing supply chain reliability and reducing manufacturing costs for pharmaceutical intermediates globally.
Patent CN114591369B discloses a spirocyclic phosphoramidite ligand enabling high enantioselectivity in palladium-catalyzed reactions, offering robust supply chain solutions.
Patent CN118852302A reveals a novel silyl migration process for nucleoside intermediates, offering significant yield improvements and supply chain reliability for pharmaceutical manufacturing.
Novel preparation method for N6-Bz-A-S-GNA phosphoramidite ensures high purity and scalability. Cost-effective solution for oligonucleotide manufacturing supply chains.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN113444125A reveals high-ee ligand for alkaloid synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Novel spirocyclic phosphoramidite ligands offer high stability and >99% ee for API synthesis, ensuring reliable supply and cost efficiency.
Novel catalytic process for nucleic acid intermediates ensuring high purity and reduced purification complexity for industrial scale production.
Novel C-P bond modification strategy enhances siRNA stability and Ago2 affinity. Reliable supplier for complex oligonucleotide intermediates with scalable solid-phase synthesis.
Patent CN121248673A details (2S)-UNA monomer synthesis enabling 5-prime to 3-prime oligonucleotide assembly with enhanced stability and supply chain reliability.
Patent CN104211741B reveals a scalable synthesis method for deuterated thymidine phosphoramidites, offering high purity and cost-effective manufacturing solutions for global research.
Patent CN101166708B details a high-yield copper-catalyzed method for (R)-muscone using novel phosphoramidite ligands and enolate scavengers, offering cost-effective scale-up potential.
Patent CN108738321B details novel GalNAc phosphoramidites for oligonucleotide conjugates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN110590886B details a novel 6'-nitrile LNA synthesis enhancing nuclease resistance. Discover scalable routes for high-affinity oligonucleotide intermediates.
Patent CN118165059A reveals a novel synthesis for stable DNA monomers. Discover cost-effective manufacturing and reliable supply chain solutions for oligonucleotide production.
Patent CN109503689B reveals a novel Guadecitabine synthesis route eliminating toxic reagents. Discover cost reduction strategies and scalable manufacturing insights for pharmaceutical intermediates.
Patent CN103848876B details a novel nucleoside phosphoramidite prodrug synthesis offering superior HCV inhibition and streamlined manufacturing for pharmaceutical supply chains.
Novel phosphoramidite ligand enables high-yield hydroformylation for BDO intermediates with enhanced catalyst stability and recycling capabilities.
Advanced synthesis of 4-(2,4,6-trimethylphenoxy)-5-fluorouracil derivatives via patent CN102532227A. Offers cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Patent CN115490732B discloses a novel one-pot synthesis for chiral biphenyl diol selenium sulfide catalysts offering mild conditions and cost-effective manufacturing for fine chemical intermediates.